Optofluidic platform consumables for antibody discovery (covid-19 response)
Ended Purchase Order Awarded Last action
- Contract number
- 75N93020P00429
- Awardee
-
Bruker Cellular Analysis, Inc. UEI C1DAMF6GN5R5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $367,763
Award facts
- Opportunity
-
- Optofluidic Platform Consumables for Antibody Discovery (COVID-19 RESPONSE) Limited / Sole Source Justification · Posted Mar 31, 2020
- Contract value 100% obligated
- $367,763.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Emeryville, CA 94608, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$331,949 | |
| Other Administrative Action | $0 | |
| Original award | $699,712 |
About this award
Bruker Cellular Analysis, Inc. was awarded a $367,763 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide optofluidic platform consumables for antibody discovery in support of COVID-19 response efforts. As part of its mission to accelerate and expand biomedical research on infectious diseases, the NIH-NIAID is utilizing Bruker's single-cell analysis technology and consumables to facilitate rapid antibody discovery and development against the SARS-CoV-2 virus. The one-year contract will be performed in Oakland, California by Bruker Cellular Analysis, Inc., with no subcontractors, and supports the agency's priority goal of responding to the coronavirus pandemic through innovative biomedical research initiatives.
Quick answers
Who was awarded contract 75N93020P00429?
75N93020P00429 was awarded to Bruker Cellular Analysis, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 26, 2020.
How much is contract 75N93020P00429 worth?
The government has obligated $367,763 on 75N93020P00429.
Was contract 75N93020P00429 competed?
The extent of competition for 75N93020P00429 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award